ISSN 1673-3770 CN 37-1437/R
Journal of Otolaryngology and Ophthalmology of Shandong University ›› 2023, Vol. 37 ›› Issue (5): 123-127.doi: 10.6040/j.issn.1673-3770.0.2022.444
• Original Article • Previous Articles Next Articles
ZHAO Hui, HUANG Chao, CUI Wenxuan, SI Mingwei, YANG Mengyao, WANG Hong, ZHOU Fang
CLC Number:
| [1] Chan CC, Rubenstein JL, Coupland SE, et al. Primary vitreoretinal lymphoma: a report from an international primary central nervous system lymphoma collaborative group symposium[J]. Oncologist, 2011, 16(11): 1589-1599. doi:10.1634/theoncologist.2011-0210 [2] Sagoo MS, Mehta H, Swampillai AJ, et al. Primary intraocular lymphoma[J]. Surv Ophthalmol, 2014, 59(5): 503-516. doi:10.1016/j.survophthal.2013.12.001 [3] 蒋婷婷, 李睿文, 刘师学, 等. 原发性玻璃体视网膜淋巴瘤: 10年诊治回顾[J]. 中华眼底病杂志, 2022(5): 376-381. doi:10.3760/cma.j.cn511434-20220310-00126 Jiang TT, Li RW, Liu SX, et al. The diagnosis and treatment of primary vitreoretinal lymphoma: 10 years of experience[J]. Chinese Journal of Ocular Fundus Diseases, 2022(5): 376-381.doi:10.3760/cma.j.cn511434-20220310-00126 [4] Pulido JS, Johnston PB, Nowakowski GS, et al. Correction to: the diagnosis and treatment of primary vitreoretinal lymphoma: a review[J]. Int J Retina Vitreous, 2018, 4: 22. doi:10.1186/s40942-018-0126-y [5] Chan CC, Sen HN. Current concepts in diagnosing and managing primary vitreoretinal(intraocular)lymphoma[J]. Discov Med, 2013, 15(81): 93-100. [6] Pulido JS, Johnston PB, Nowakowski GS, et al. The diagnosis and treatment of primary vitreoretinal lymphoma: a review[J]. Int J Retina Vitreous, 2018, 4: 18. doi:10.1186/s40942-018-0120-4 [7] Whitcup SM, Stark-Vancs V, Wittes RE, et al. Association of interleukin 10 in the vitreous and cerebrospinal fluid and primary central nervous system lymphoma[J]. Arch Ophthalmol, 1997, 115(9): 1157-1160. doi:10.1001/archopht.1997.01100160327010 [8] Finger PT, Papp C, Latkany P, et al. Anterior chamber paracentesis cytology(cytospin technique)for the diagnosis of intraocular lymphoma[J]. Br J Ophthalmol, 2006, 90(6): 690-692. doi:10.1136/bjo.2005.087346 [9] Frenkel S, Pe'er J, Kaufman R, et al. The importance of cytokines analysis in the diagnosis of vitreoretinal lymphoma[J]. Acta Ophthalmol, 2020, 98(6): e668-e673. doi:10.1111/aos.14347 [10] Coupland SE, Hummel M, Müller HH, et al. Molecular analysis of immunoglobulin genes in primary intraocular lymphoma[J]. Invest Ophthalmol Vis Sci, 2005, 46(10): 3507-3514. doi:10.1167/iovs.05-0401 [11] Tanaka R, Kaburaki T, Taoka K, et al. More accurate diagnosis of vitreoretinal lymphoma using a combination of diagnostic test results: a prospective observational study[J]. Ocular Immunol Inflamm, 2022, 30(6): 1354-1360. doi:10.1080/09273948.2021.1873394 [12] Sehgal A, Pulido JS, Mashayekhi A, et al. Diagnosing vitreoretinal lymphomas-an analysis of the sensitivity of existing tools[J]. Cancers, 2022, 14(3): 598. doi:10.3390/cancers14030598 [13] 陈秀菊, 常青, 江睿, 等. 玻璃体腔注射甲氨蝶呤治疗玻璃体视网膜淋巴瘤14例[J]. 中华眼底病杂志, 2016, 32(4): 399-403. doi:10.3760/cma.j.issn.1005-1015.2016.04.013 CHEN Xiuju, CHANG Qing, JIANG Rui, et al. Intravitreal methotrexate chemotherapy in the treatment of 14 patients with priamary vitreoretinal lymphoma[J]. Chinese Journal of Ocular Fundus Diseases, 2016, 32(4): 399-403. doi:10.3760/cma.j.issn.1005-1015.2016.04.013 [14] 朱婕, 李喆, 徐敏, 等. 原发于中枢神经系统淋巴瘤的眼内淋巴瘤1例[J]. 中华眼底病杂志, 2022, 38(7): 601-603. doi:10.3760/cma.j.cn511434-20210824-00458 ZHU Jie, LI Zhe, XU Min, et al. Intraocular lymphoma with primary central nervous system lymphoma: a case report[J]. Chinese Journal of Ocular Fundus Diseases, 2022, 38(7): 601-603. doi:10.3760/cma.j.cn511434-20210824-00458 [15] Frenkel S, Hendler K, Siegal T, et al. Intravitreal methotrexate for treating vitreoretinal lymphoma: 10 years of experience[J]. Br J Ophthalmol, 2008, 92(3): 383-388. doi:10.1136/bjo.2007.127928 [16] Castellino A, Pulido JS, Johnston PB, et al. Role of systemic high-dose methotrexate and combined approaches in the management of vitreoretinal lymphoma: a single center experience 1990-2018[J]. Am J Hematol, 2019, 94(3): 291-298. doi:10.1002/ajh.25350 [17] Bannwarth B, Péhourcq F, Schaeverbeke T, et al. Clinical pharmacokinetics of low-dose pulse methotrexate in rheumatoid arthritis[J]. Clin Pharmacokinet, 1996, 30(3): 194-210. doi:10.2165/00003088-199630030-00002 [18] Rizkalla K, Rodrigues S, Proulx A, et al. Primary intraocular lymphoma arising during methotrexate treatment of temporal arteritis[J]. Can J Ophthalmol, 2005,40(5):585-592. doi: 10.1016/S0008-4182(05)80050-X [19] Gill MK, Jampol LM. Variations in the presentation of primary intraocular lymphoma: case reports and a review[J]. Surv Ophthalmol, 2001, 45(6): 463-471. doi:10.1016/s0039-6257(01)00217-x [20] Gass JD, Trattler HL. Retinal artery obstruction and atheromas associated with non-Hodgkin's large cell lymphoma(reticulum cell sarcoma)[J]. Arch Ophthalmol, 1991, 109(8): 1134-1139. doi:10.1001/archopht.1991.01080080094039 [21] Gezer S, Vural B, Kirsavoglu M, et al. Branch retinal artery occlusion in a patient undergoing Methotrexate therapy for ectopic pregnancy: a case report[J]. J Pak Med Assoc, 2020, 70(2): 357-359. doi:10.5455/JPMA.14284 [22] Fierz AB, Sartoretti S, Thoelen AM. Optic neuropathy and central retinal artery occlusion in non-Hodgkin lymphoma[J]. J Neuroophthalmol, 2001, 21(2): 103-105. doi:10.1097/00041327-200106000-00009 [23] 赵兴贺, 樊明月, 窦训武, 等. 儿童原发扁桃体弥漫大B细胞淋巴瘤1例并文献复习[J]. 山东大学耳鼻喉眼学报, 2022, 36(1): 120-124. doi:10.6040/j.issn.1673-3770.0.2021.366 ZHAO Xinghe, FAN Mingyue, DOU Xunwu, et al. Primary large B-cell lymphoma of tonsil in children: a case report and document review[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(1): 120-124. doi:10.6040/j.issn.1673-3770.0.2021.366 [24] Carbonell D, Mahajan S, Chee SP, et al. Consensus recommendations for the diagnosis of vitreoretinal lymphoma[J]. Ocul Immunol Inflamm, 2021, 29(3): 507-520. doi:10.1080/09273948.2021.1878233 [25] Habot-Wilner Z, Frenkel S, Pe'er J. Efficacy and safety of intravitreal methotrexate for vitreo-retinal lymphoma- 20 years of experience[J]. Br J Haematol, 2021, 194(1): 92-100. doi:10.1111/bjh.17451 |
| [1] | ZHU Mingqiong, LI Zheng, LIU Ru, TIAN Tao, PENG Jingli, LYU Qianyi, TAN Huaxia. The application of AI screening system based on OCT/OCTA in the evaluation of the effect of anti VEGF treatment in patients with diabetes macular edema [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2026, 40(1): 68-73. |
| [2] | LU Zhaoyang, ZHAI Zhaoxue, WANG Huikang, SHAO Liting, ZHANG Yu. COVID-19 treatment-induced diabetic ketoacidosis combined with rhino-orbital cerebral mucormycosis: a case report and literature review [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2026, 40(1): 90-94. |
| [3] | LIU Yijie, LU Xiuzhen, WU Qiuxin. Research rogress of exosomes in the pathogenesis, diagnosis and treatment in ophthalmic diseases [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2026, 40(1): 135-141. |
| [4] | LI Zan, LU Qi, SHEN Weidong, HOU Zhaohui, WU Nan. Clinical diagnosis and treatment features of 18 cases of necrotizing otitis externa [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(6): 17-22. |
| [5] | LIU Yuzhu, CHEN Yao, YUAN Tiejun, LI Chunsen, LI Bo. Larynx fibrosarcoma: a case report and literature review [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(6): 133-137. |
| [6] | GU Zhanxin, ZHAO Zhouyang, ZHANG Xiaobin, YANG Yimei, HUANG Lijin, HUANG Yan. Syndrome differentiation treatment and understanding of traditional Chinese medicine in carotid blowout syndrome [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(4): 100-107. |
| [7] | SHI Jinlian, LI Jianxing, HUANG Yousheng, LIN Mingxuan, LIU Lingyun, LU Yongtian. Research status and progress in diagnosis and treatment of laryngeal inflammatory myofibroblastic tumor [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(4): 186-192. |
| [8] | WU Wei, WANG Lei, CHEN Sheng, LI Lianyong, WANG Gang. Multidisciplinary research and advances in gastro-oesophageal reflux disease [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(6): 1-14. |
| [9] | LIU Lianlian, LI Jinrang. Obstructive sleep apnea and laryngopharyngeal reflux [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(6): 15-22. |
| [10] | ZHU Lang, LIU Zhiqi. Utilization of real-world data from mobile health applications in therapeutic interventions for allergic rhinitis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(4): 135-139. |
| [11] | LI Shuting, ZHAO Hui, SI Mingwei, CUI Wenxuan, YANG Mengyao, WANG Hong. Central retinal artery occlusion caused by facial filling with hyaluronic acid: a case report and literature review [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(1): 66-71. |
| [12] | ZHOU Yuhong, DENG Yingping. Progress of corneal collagen cross-linking for the treatment of thin keratoconic corneas [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(1): 115-121. |
| [13] | ZONG Chunlin, LU Jinbiao, YANG Yong, SU Zhongping, YU Bo. Application study of the MDT module combined with a flipped classroom in clinical teaching of pediatric OSA [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2023, 37(6): 139-144. |
| [14] | ZHANG Xiaohan, WEI Li, YANG Kaili, CHEN Haiyan, LI Yansong, WANG Ping. Study on the change of OCTA and its correlation with visual acuity in patients with CSC before and after TCM syndrome differentiation and treatment [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2023, 37(5): 115-122. |
| [15] | JIN Jing, LENG Hui. Progress in treatment of olfactory dysfunction following SARS-Cov-2 [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2023, 37(5): 162-174. |
|
||